Similar to AML, CML, and CLL, blockage of the CXCR4/CXCL12 pathway by AMD3100 is also being investigated in multiple myeloma and other hematopoietic cancers. The gene discussed is CXCR4; the disease is B-cell chronic lymphocytic leukemia.